These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12619930)

  • 1. CytokineRegulation and the signaling mechanism of osteoclast inhibitory peptide-1 (OIP-1/hSca) to inhibit osteoclast formation.
    Koide M; Maeda H; Roccisana JL; Kawanabe N; Reddy SV
    J Bone Miner Res; 2003 Mar; 18(3):458-65. PubMed ID: 12619930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the functional domain of osteoclast inhibitory peptide-1/hSca.
    Koide M; Kurihara N; Maeda H; Reddy SV
    J Bone Miner Res; 2002 Jan; 17(1):111-8. PubMed ID: 11771657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of human osteoclast inhibitory peptide-1 (OIP-1/hSca) gene promoter.
    Srinivasan S; Ito M; Kajiya H; Key LL; Johnson-Pais TL; Reddy SV
    Gene; 2006 Apr; 371(1):16-24. PubMed ID: 16380218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoclast inhibitory peptide-1 (OIP-1) inhibits measles virus nucleocapsid protein stimulated osteoclast formation/activity.
    Shanmugarajan S; Youssef RF; Pati P; Ries WL; Rao DS; Reddy SV
    J Cell Biochem; 2008 Jul; 104(4):1500-8. PubMed ID: 18348201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K; Kudo A
    J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
    Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
    J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production.
    Lee SK; Gardner AE; Kalinowski JF; Jastrzebski SL; Lorenzo JA
    Bone; 2006 May; 38(5):678-85. PubMed ID: 16309985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
    Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
    J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophil chemotactic factor-L (ECF-L): a novel osteoclast stimulating factor.
    Oba Y; Chung HY; Choi SJ; Roodman GD
    J Bone Miner Res; 2003 Jul; 18(7):1332-41. PubMed ID: 12854845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-32alpha induction in human pancreatic periacinar myofibroblasts.
    Nishida A; Andoh A; Shioya M; Kim-Mitsuyama S; Takayanagi A; Fujiyama Y
    Am J Physiol Gastrointest Liver Physiol; 2008 Mar; 294(3):G831-8. PubMed ID: 18239058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-myc is required for osteoclast differentiation.
    Battaglino R; Kim D; Fu J; Vaage B; Fu XY; Stashenko P
    J Bone Miner Res; 2002 May; 17(5):763-73. PubMed ID: 12009006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of human osteoclast differentiation by thioredoxin binding protein-2 and redox-sensitive signaling.
    Aitken CJ; Hodge JM; Nishinaka Y; Vaughan T; Yodoi J; Day CJ; Morrison NA; Nicholson GC
    J Bone Miner Res; 2004 Dec; 19(12):2057-64. PubMed ID: 15537450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction.
    Kanatani M; Sugimoto T; Sowa H; Kobayashi T; Kanzawa M; Chihara K
    J Cell Physiol; 2004 Oct; 201(1):17-25. PubMed ID: 15281085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase.
    Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K
    J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
    Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
    Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (5R)-5-hydroxytriptolide inhibits IFN-gamma-related signaling.
    Zhou R; Wang JX; Tang W; He PL; Yang YF; Li YC; Li XY; Zuo JP
    Acta Pharmacol Sin; 2006 Dec; 27(12):1616-21. PubMed ID: 17112417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible involvement of protein kinases and Smad2 signaling pathways on osteoclast differentiation enhanced by activin A.
    Murase Y; Okahashi N; Koseki T; Itoh K; Udagawa N; Hashimoto O; Sugino H; Noguchi T; Nishihara T
    J Cell Physiol; 2001 Aug; 188(2):236-42. PubMed ID: 11424090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.
    Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T
    Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis.
    Merle B; Itzstein C; Delmas PD; Chenu C
    J Cell Biochem; 2003 Oct; 90(2):424-36. PubMed ID: 14505357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.